MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868905. A total of 4 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,272 | -18.4% | 49,800 | +29.0% | 0.01% | -14.3% |
| Q2 2023 | $8,916 | -13.6% | 38,600 | -9.4% | 0.01% | -22.2% |
| Q1 2023 | $10,320 | -28.0% | 42,600 | -13.8% | 0.01% | -43.8% |
| Q4 2022 | $14,338 | -99.2% | 49,400 | +90.0% | 0.02% | +700.0% |
| Q3 2022 | $1,689,000 | +402.7% | 26,000 | +453.2% | 0.00% | – |
| Q2 2022 | $336,000 | +187.2% | 4,700 | +291.7% | 0.00% | – |
| Q1 2022 | $117,000 | -83.4% | 1,200 | -85.5% | 0.00% | -100.0% |
| Q4 2021 | $703,000 | +172.5% | 8,300 | +219.2% | 0.00% | – |
| Q3 2021 | $258,000 | +2.0% | 2,600 | 0.0% | 0.00% | – |
| Q2 2021 | $253,000 | +14.0% | 2,600 | +13584.2% | 0.00% | – |
| Q1 2021 | $222,000 | -85.2% | 19 | -85.9% | 0.00% | -100.0% |
| Q4 2020 | $1,500,000 | +78.1% | 135 | +90.1% | 0.00% | +100.0% |
| Q3 2020 | $842,000 | +398.2% | 71 | +373.3% | 0.00% | – |
| Q2 2020 | $169,000 | +131.5% | 15 | +36.4% | 0.00% | – |
| Q1 2020 | $73,000 | -52.6% | 11 | -35.3% | 0.00% | – |
| Q4 2019 | $154,000 | -14.9% | 17 | -19.0% | 0.00% | -100.0% |
| Q3 2019 | $181,000 | +1.7% | 21 | +23.5% | 0.00% | – |
| Q2 2019 | $178,000 | -85.3% | 17 | -82.5% | 0.00% | -100.0% |
| Q1 2019 | $1,215,000 | +34.9% | 97 | +21.2% | 0.00% | 0.0% |
| Q4 2018 | $901,000 | -26.1% | 80 | +40.4% | 0.00% | -25.0% |
| Q3 2018 | $1,220,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 374,300 | $54,662,772 | 0.18% |
| JANE STREET GROUP, LLC | 265,600 | $38,788,224 | 0.01% |
| SIMPLEX TRADING, LLC | 49,800 | $7,272 | 0.01% |
| JPMORGAN CHASE & CO | 73,500 | $10,733,940 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |